Wells Fargo & Company lowered shares of Imperva Inc (NYSE:IMPV) from an outperform rating to a market perform rating in a research report sent to investors on Monday morning, The Fly reports.

A number of other brokerages have also weighed in on IMPV. Stifel Nicolaus reaffirmed a hold rating and issued a $47.00 target price on shares of Imperva in a research note on Friday, July 14th. Stephens reaffirmed an overweight rating and issued a $61.00 target price (up from $53.00) on shares of Imperva in a research note on Thursday, July 13th. BidaskClub lowered shares of Imperva from a buy rating to a hold rating in a research note on Tuesday, July 25th. ValuEngine lowered shares of Imperva from a hold rating to a sell rating in a research note on Tuesday, July 11th. Finally, Monness Crespi & Hardt upped their target price on shares of Imperva from $55.00 to $57.00 and gave the stock a buy rating in a research note on Friday, July 28th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have given a buy rating to the company. The stock has an average rating of Hold and an average target price of $52.34.

Imperva (IMPV) traded up 0.11% during mid-day trading on Monday, hitting $43.55. The stock had a trading volume of 13,720 shares. The company has a 50-day moving average price of $44.05 and a 200 day moving average price of $45.81. Imperva has a 1-year low of $34.40 and a 1-year high of $52.40. The company’s market cap is $1.47 billion.

Imperva (NYSE:IMPV) last announced its quarterly earnings results on Thursday, July 27th. The software maker reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.05 by ($0.15). Imperva had a negative net margin of 4.69% and a negative return on equity of 5.00%. The firm had revenue of $74.44 million during the quarter, compared to analyst estimates of $74.30 million. During the same period last year, the firm earned ($0.23) EPS. Imperva’s quarterly revenue was up 28.6% on a year-over-year basis. Equities research analysts forecast that Imperva will post $0.81 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This piece of content was reported by Daily Political and is the property of of Daily Political. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. & international copyright and trademark laws. The legal version of this piece of content can be accessed at https://www.dailypolitical.com/2017/10/13/imperva-inc-impv-rating-lowered-to-market-perform-at-wells-fargo-company.html.

In other Imperva news, Director Anthony J. Bettencourt sold 99,598 shares of the stock in a transaction that occurred on Thursday, August 24th. The shares were sold at an average price of $43.59, for a total transaction of $4,341,476.82. Following the transaction, the director now owns 99,598 shares in the company, valued at approximately $4,341,476.82. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 2.20% of the company’s stock.

Large investors have recently made changes to their positions in the business. Capital Fund Management S.A. grew its position in shares of Imperva by 85.6% during the 2nd quarter. Capital Fund Management S.A. now owns 113,951 shares of the software maker’s stock worth $5,453,000 after purchasing an additional 52,559 shares in the last quarter. Wells Fargo & Company MN grew its position in shares of Imperva by 86.5% during the 2nd quarter. Wells Fargo & Company MN now owns 191,212 shares of the software maker’s stock worth $9,149,000 after purchasing an additional 88,701 shares in the last quarter. Bank of Nova Scotia acquired a new position in shares of Imperva during the 1st quarter worth approximately $7,184,000. Eagle Asset Management Inc. grew its position in shares of Imperva by 17.7% during the 2nd quarter. Eagle Asset Management Inc. now owns 1,279,848 shares of the software maker’s stock worth $61,240,000 after purchasing an additional 192,625 shares in the last quarter. Finally, Weiss Multi Strategy Advisers LLC grew its position in shares of Imperva by 127.3% during the 1st quarter. Weiss Multi Strategy Advisers LLC now owns 25,000 shares of the software maker’s stock worth $1,026,000 after purchasing an additional 14,000 shares in the last quarter. Hedge funds and other institutional investors own 92.72% of the company’s stock.

About Imperva

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

The Fly

Analyst Recommendations for Imperva (NYSE:IMPV)

Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with MarketBeat.com's FREE daily email newsletter.